Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

referredUnited States· United States Congress· EN

Introduced

6 May 2008

Last action

7 May 2008 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Ross, Mike [D-AR-4], Rep. Emerson, Jo Ann [R-MO-8], Sen. Baldwin, Tammy [D-WI], Rep. Burgess, Michael C. [R-TX-26], Rep. Farr, Sam [D-CA-20], Rep. Carter, John R. [R-TX-31], Rep. Giffords, Gabrielle [D-AZ-8], Rep. Paul, Ron [R-TX-14], Rep. Wamp, Zach [R-TN-3], Rep. Thornberry, Mac [R-TX-13], Rep. Granger, Kay [R-TX-12], Rep. Brown-Waite, Ginny [R-FL-5], Rep. Hall, Ralph M. [R-TX-4], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Berry, Marion [D-AR-1], Rep. Kuhl, John R. "Randy", Jr. [R-NY-29], Rep. Bishop, Rob [R-UT-1], Rep. Chandler, Ben [D-KY-6], Rep. Shays, Christopher [R-CT-4], Sen. Boozman, John [R-AR], Rep. Stearns, Cliff [R-FL-6], Rep. Wexler, Robert [D-FL-19], Rep. Weller, Jerry [R-IL-11], Rep. Doyle, Michael F. [D-PA-14], Rep. McCaul, Michael T. [R-TX-10], Rep. Michaud, Michael H. [D-ME-2], Rep. Snyder, Vic [D-AR-2], Rep. Pastor, Ed [D-AZ-4], Rep. Lofgren, Zoe [D-CA-18], Rep. Cooper, Jim [D-TN-5], Rep. Allen, Thomas H. [D-ME-1], Rep. Burton, Dan [R-IN-5], Rep. Murphy, Tim [R-PA-18], Rep. Miller, Jeff [R-FL-1], Rep. Musgrave, Marilyn N. [R-CO-4], Rep. Goode, Virgil H., Jr. [R-VA-5], Rep. Eshoo, Anna G. [D-CA-18], Rep. Mitchell, Harry E. [D-AZ-5], Rep. Boren, Dan [D-OK-2], Rep. Gonzalez, Charles A. [D-TX-20], Rep. LaHood, Ray [R-IL-18], Rep. Bachus, Spencer [R-AL-6], Rep. Boyda, Nancy E. [D-KS-2], Rep. Gohmert, Louie [R-TX-1], Rep. Franks, Trent [R-AZ-8], Rep. Tiberi, Patrick J. [R-OH-12], Rep. Bonner, Jo [R-AL-1], Rep. Sánchez, Linda T. [D-CA-38]

Subjects

Healthcare

Source updated

5 February 2024

Healthcare

Official source Download file View documents Share

Summary

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

6 May 2008
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
6 May 2008
Introduced
Introduced in House
Source: IntroReferral
6 May 2008
Introduced
Introduced in House
Source: IntroReferral
7 May 2008
Referred
Referred to the Subcommittee on Health.
Source: Committee

Votes

No vote records are attached yet.

Versions

Introduced in House · 6 May 2008 · Download file

Documents

3 official files

Introduced in House (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Introduced in House (text)
Introduced in House · EN · 6 May 2008
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 6 May 2008
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 6 May 2008
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to ← A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/110th-congress/house-concurrent-resolution/342
Open data entity: https://api.congress.gov/v3/bill/110/hconres/342
us · 110-hconres-342 · source updated 5 February 2024